Dexcom (DXCM) Retained Earnings (2010 - 2026)

Dexcom (DXCM) has 17 years of Retained Earnings data on file, last reported at $2.6 billion in Q1 2026.

• On a quarterly basis, Retained Earnings rose 54.63% year-over-year to $2.6 billion in Q1 2026; TTM through Mar 2026 was $2.6 billion, a 54.63% increase from a year earlier, with the FY2025 full-year figure at $2.4 billion, up 30523.75% from the prior year.
• Retained Earnings for Q1 2026 stood at $2.6 billion, up from $2.4 billion in the prior quarter.
• Over the last five years, Retained Earnings for DXCM reached as high as $2.6 billion in Q1 2026 and fell as low as -$35.6 million in Q3 2023.
• Historically, Retained Earnings has averaged $891.2 million across 5 years, with a median of $644.4 million in 2023.
• Across the five-year window, Retained Earnings sank 2420.0% in 2022 and surged 30523.75% in 2025, its largest moves.
• Year by year, Retained Earnings stood at -$11.6 million in 2022, then surged by 8905.17% to $1.0 billion in 2023, then plunged by 100.78% to -$8.0 million in 2024, then jumped by 30523.75% to $2.4 billion in 2025, then grew by 8.2% to $2.6 billion in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $2.6 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.2 billion in Q3 2025.